文献速递儿科与产科急症

妊娠期体重增加与母婴结局的关联:系统综述与Meta分析

Association of Gestational Weight Gain With Maternal and Infant Outcomes: A Systematic Review and Meta-analysis.
PubMed 文献 · JAMA · 2017-01-01
一句话结论超百万孕妇Meta分析:47%孕期增重超IOM推荐、23%低于推荐,偏离推荐均与母婴不良结局风险升高相关。

该系统综述与Meta分析检索1999年1月1日至2017年2月7日EMBASE、EBMR、MEDLINE及MEDLINE In-Process数据库,纳入23项按孕前BMI分层报告总孕期增重的观察性研究,共1 309 136名孕妇。以美国医学研究所(IOM)2009年孕期增重推荐(低体重12.5–18 kg、正常体重11.5–16 kg、超重7–11 kg、肥胖5–9 kg)为参照,采用随机效应模型计算OR与每活产绝对风险差(ARD)。结果显示增重低于推荐与小于胎龄儿(OR 1.53)和早产(OR 1.70)风险升高相关,增重高于推荐与大于胎龄儿(OR 1.85)、巨大儿(OR 1.95)和剖宫产(OR 1.30)风险升高相关;妊娠期糖尿病因现有数据性质无法评估。

要点

  • 23项观察性研究、1 309 136名孕妇中,孕期增重高于IOM推荐者占47%,低于推荐者占23%。
  • 增重低于推荐:小于胎龄儿OR 1.53(95%CI 1.44–1.64;ARD 5%),早产OR 1.70(95%CI 1.32–2.20;ARD 5%)。
  • 增重高于推荐:大于胎龄儿OR 1.85(95%CI 1.76–1.95;ARD 4%),巨大儿OR 1.95(95%CI 1.79–2.11;ARD 6%)。
  • 增重高于推荐者剖宫产风险升高(OR 1.30,95%CI 1.25–1.35;ARD 4%),低于推荐者剖宫产无显著差异(OR 0.98,95%CI 0.96–1.02)。
  • 妊娠期糖尿病因现有数据性质无法评估。

适用人群与场景

  • 孕前按BMI分类的孕妇:低体重(BMI<18.5)、正常体重(BMI 18.5–24.9)、超重(BMI 25–29.9)、肥胖(BMI≥30)。
  • 纳入1999年1月1日至2017年2月7日发表的、按孕前BMI类别和总孕期增重分层的观察性研究。

诊断标准与关键阈值

  • IOM 2009年孕期增重推荐:低体重孕妇增重12.5–18 kg;正常体重孕妇11.5–16 kg;超重孕妇7–11 kg;肥胖孕妇5–9 kg。
  • 低于推荐指总孕期增重低于上述对应BMI类别下限,高于推荐指超过上限。

研究设计与关键结果

  • 研究类型:系统综述与Meta分析,纳入23项观察性研究(n=1 309 136名孕妇),检索EMBASE、EBMR、MEDLINE及MEDLINE In-Process。
  • 增重低于推荐与小于胎龄儿风险升高相关(OR 1.53,95%CI 1.44–1.64;ARD 5%,95%CI 4%–6%)及早产风险升高相关(OR 1.70,95%CI 1.32–2.20;ARD 5%,95%CI 3%–8%)。
  • 增重低于推荐与大于胎龄儿风险降低相关(OR 0.59,95%CI 0.55–0.64;ARD −2%,95%CI −10%至−6%)及巨大儿风险降低相关(OR 0.60,95%CI 0.52–0.68;ARD −2%,95%CI −3%至−1%)。
  • 增重低于推荐者剖宫产无显著差异(OR 0.98,95%CI 0.96–1.02;ARD 0%,95%CI −2%至1%)。
  • 增重高于推荐与小于胎龄儿风险降低相关(OR 0.66,95%CI 0.63–0.69;ARD −3%,95%CI −4%至−2%)及早产风险降低相关(OR 0.77,95%CI 0.69–0.86;ARD −2%,95%CI −2%至−1%)。
  • 增重高于推荐与大于胎龄儿风险升高相关(OR 1.85,95%CI 1.76–1.95;ARD 4%,95%CI 2%–5%)、巨大儿风险升高相关(OR 1.95,95%CI 1.79–2.11;ARD 6%,95%CI 4%–9%)及剖宫产风险升高相关(OR 1.30,95%CI 1.25–1.35;ARD 4%,95%CI 3%–6%)。
  • 妊娠期糖尿病因现有数据性质无法评估。

证据类型、等级与局限

  • 证据类型:系统综述与Meta分析,纳入23项观察性研究,采用随机效应模型计算OR与ARD。
  • 局限:妊娠期糖尿病因现有数据性质无法评估。

对床旁实践的改变

  • 作者结论认为,孕期增重高于或低于IOM指南推荐(与增重在推荐范围内相比)与母婴不良结局风险升高相关。

指南或共识出处

  • 美国医学研究所(IOM)2009年孕期增重推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Body mass index (BMI) and gestational weight gain are increasing globally. In 2009, the Institute of Medicine (IOM) provided specific recommendations regarding the ideal gestational weight gain. However, the association between gestational weight gain consistent with theIOM guidelines and pregnancy outcomes is unclear.

OBJECTIVE: To perform a systematic review, meta-analysis, and metaregression to evaluate associations between gestational weight gain above or below the IOM guidelines (gain of 12.5-18 kg for underweight women [BMI <18.5]; 11.5-16 kg for normal-weight women [BMI 18.5-24.9]; 7-11 kg for overweight women [BMI 25-29.9]; and 5-9 kg for obese women [BMI ≥30]) and maternal and infant outcomes.

DATA SOURCES AND STUDY SELECTION: Search of EMBASE, Evidence-Based Medicine Reviews, MEDLINE, and MEDLINE In-Process between January 1, 1999, and February 7, 2017, for observational studies stratified by prepregnancy BMI category and total gestational weight gain.

DATA EXTRACTION AND SYNTHESIS: Data were extracted by 2 independent reviewers. Odds ratios (ORs) and absolute risk differences (ARDs) per live birth were calculated using a random-effects model based on a subset of studies with available data.

MAIN OUTCOMES AND MEASURES: Primary outcomes were small for gestational age (SGA), preterm birth, and large for gestational age (LGA). Secondary outcomes were macrosomia, cesarean delivery, and gestational diabetes mellitus.

RESULTS: Of 5354 identified studies, 23 (n = 1 309 136 women) met inclusion criteria. Gestational weight gain was below or above guidelines in 23% and 47% of pregnancies, respectively. Gestational weight gain below the recommendations was associated with higher risk of SGA (OR, 1.53 [95% CI, 1.44-1.64]; ARD, 5% [95% CI, 4%-6%]) and preterm birth (OR, 1.70 [1.32-2.20]; ARD, 5% [3%-8%]) and lower risk of LGA (OR, 0.59 [0.55-0.64]; ARD, -2% [-10% to -6%]) and macrosomia (OR, 0.60 [0.52-0.68]; ARD, -2% [-3% to -1%]); cesarean delivery showed no significant difference (OR, 0.98 [0.96-1.02]; ARD, 0% [-2% to 1%]). Gestational weight gain above the recommendations was associated with lower risk of SGA (OR, 0.66 [0.63-0.69]; ARD, -3%; [-4% to -2%]) and preterm birth (OR, 0.77 [0.69-0.86]; ARD, -2% [-2% to -1%]) and higher risk of LGA (OR, 1.85 [1.76-1.95]; ARD, 4% [2%-5%]), macrosomia (OR, 1.95 [1.79-2.11]; ARD, 6% [4%-9%]), and cesarean delivery (OR, 1.30 [1.25-1.35]; ARD, 4% [3%-6%]). Gestational diabetes mellitus could not be evaluated because of the nature of available data.

CONCLUSIONS AND RELEVANCE: In this systematic review and meta-analysis of more than 1 million pregnant women, 47% had gestational weight gain greater than IOM recommendations and 23% had gestational weight gain less than IOM recommendations. Gestational weight gain greater than or less than guideline recommendations, compared with weight gain within recommended levels, was associated with higher risk of adverse maternal and infant outcomes.

来源:JAMA,查看原文。版权归原作者所有。

参考来源

  1. Goldstein RF, Abell SK, Ranasinha S, et al. Association of Gestational Weight Gain With Maternal and Infant Outcomes: A Systematic Review and Meta-analysis. JAMA. 2017. PMID: 28586887. doi:10.1001/jama.2017.3635

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。